Article
A Five Immune-Related lncRNA Signature as a Prognostic Target for Glioblastoma
16 Feb 2021
Abstract excerpt
Background: A variety of regulatory approaches including immune modulation have been explored as approaches to either eradicate antitumor response or induce suppressive mechanism in the glioblastoma microenvironment. Thus, the study of immune-related long noncoding RNA (lncRNA) signature is of great value in the diagnosis, treatment, and prognosis of glioblastoma. Methods: Glioblastoma samples with lncRNA...
Topics
Join the communities discussing this publication.
